1 / 8

End Stage Renal Disease (ESRD) Drug Market

The global end stage renal disease (ESRD) drug market size is expected to grow from $101.73 billion in 2022 to $115.82 billion in 2023 at a compound annual growth rate (CAGR) of 13.9%.

Snigdha7
Download Presentation

End Stage Renal Disease (ESRD) Drug Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. End Stage Renal Disease (ESRD) Drug Global Market Report 2023 Market Size, Trends and Global Forecast 2023-2032

  2. End Stage Renal Disease (ESRD) Drug Segments The Business Research Company segments it’s End Stage Renal Disease (ESRD) Drug report as: By Product Type Calcimimetics, Vitamin D, Sterols, Potassium Binders, Calcium-Based Phosphate Binders, Other Products By Distribution Channel Hospital Pharmacy, Online Pharmacy, Retail Pharmacy By Indication End Stage Renal Disease (ESRD) Induced Hyperparathyroidism, End Stage Renal Disease (ESRD) Induced Hyperphosphatemia, End Stage Renal Disease (ESRD) Induced Hyperkalaemia By End User Hospitals, Homecare, Specialty Clinics, Other End Users

  3. Market Statistics The global end stage renal disease (ESRD) drug market size is expected to grow from $101.73 billion in 2022 to $115.82 billion in 2023 at a compound annual growth rate (CAGR) of 13.9%. The global end stage renal disease (ESRD) drug market size is expected to grow to $193.98 billion in 2027 at a CAGR of 13.8%. Click Here To Get A Sample Report

  4. Key Market Drivers And Trends • Drivers Rising cases of obesity and diabetes are expected to propel the growth of the end-stage renal disease (ESRD) drug market going forward. Trends Product innovations are a key trend in gaining popularity in the end-stage renal disease (ESRD) drug market. • Region North America was the largest region in the end stage renal disease (ESRD) drug market in 2022. The regions covered in the global end stage renal disease (ESRD) drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

  5. Key Market Players • Major players in the End Stage Renal Disease (ESRD) Drug are: • Pfizer Inc. • AstraZeneca Plc. • Sanofi SA • Astellas Pharma Inc. • Novartis AG • And more. Get More Information On The End Stage Renal Disease (ESRD) Drug Report

  6. 5 Reasons Why TBRC Is The Solution You Need • Measure the impact of high global inflation on market growth • Outperform competitors using forecast data and the drivers and trends shaping the market • Get a comprehensive market sizing report with a truly global perspective covering 60+ geographies from The Business Research Company, with data from 2017 to 2023 and forecasts up to 2032. • Assess the Russia-Ukraine war’s impact on commodity supply and its direct and indirect impact on all the markets • Benchmark performance against key competitors.

  7. Americas The Business Research Company, 1295 N Providence Rd, Media, PA 19063, USA ✆ +1 3156230293 Get In Touch Europe The Business Research Company 47 Anchorage Point, 42 Cuba Street, Canary Wharf, London, England, E14 8NE ✆ +44 207 1930 708 How ever you want to grow and expand, The Business Research Company can help as we provide research consulting solutions for businesses, government agencies consultancies, and market research companies. Asia The Business Research Company, 1st Floor, Anshu Colors Building, Road Number 1, Park View Enclave, Jubilee Hills, Hyderabad (India), 500033 ✆ +91 8897263534 info@tbrc.info

  8. Your Growth Insights Partner

More Related